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ABSTRACT
The world is suffering from a pandemic called COVID-19, caused by
the SARS-CoV-2 virus. National governments have problems eval-
uating the reach of the epidemic, due to having limited resources
and tests at their disposal. This problem is especially acute in low
and middle-income countries (LMICs). Hence, any simple, cheap
and flexible means of evaluating the incidence and evolution of the
epidemic in a given country with a reasonable level of accuracy is
useful. In this paper, we propose a technique based on (anonymous)
surveys in which participants report on the health status of their
contacts. This indirect reporting technique, known in the literature
as network scale-up method, preserves the privacy of the partici-
pants and their contacts, and collects information from a larger
fraction of the population (as compared to individual surveys). This
technique has been deployed in the CoronaSurveys project, which
has been collecting reports for the COVID-19 pandemic for more
than two months. Results obtained by CoronaSurveys show the
power and flexibility of the approach, suggesting that it could be
an inexpensive and powerful tool for LMICs.
CCS CONCEPTS
• Information systems→Crowdsourcing; •Applied comput-
ing→ Health informatics.
KEYWORDS
epidemics, surveys, crowdsourcing, privacy
1 INTRODUCTION
During the current SARS-CoV-2 virus pandemic, monitoring the
evolution of COVID-19 cases is very important for authorities to
make informed policy decisions, and for the general public to be
informed of the reach of the problem. Official numbers of confirmed
cases are periodically issued by health authorities [4]. Unfortunately,
at the early stages of a pandemic outbreak there is usually only
limited ability to test, as well as a lack of other resources. Hence, it
is not possible to test all potential cases, and some eligibility criteria
is applied to decide who is tested. Under these circumstances, the
official confirmed cases are unlikely to represent the total number
of cases (see [12]). This problem is more pressing in low and middle-
income countries (LMICs), which may be limited in their ability to
deploy massive testing. Not having access to reliable data clearly
prevents authorities from making informed decisions, putting the
population at higher risk.
This motivates the need for other probing techniques, beyond
laboratory testing, that can estimate the number of cases and their
evolution. Information obtained using these alternative methods
can be more timely, leaving more accurate estimates of the number
of cases for later studies (e.g., massive serological studies [18]).
Techniques that allow cheap and massive data collection, and lead
to reasonably accurate estimates, are useful when testing is limited
and can lead to improved data-driven decision making.
Direct surveys are an obvious approach to estimate incidence.
A number of these direct surveys to obtain health data have been
deployed in various countries in recent months [5, 10, 14]. While
these surveys can gather useful data, a large number of participants
is needed to achieve reliable estimates. Additionally, these surveys
collect sensitive personal health information, which prevents the
distribution of the raw data collected, and may also discourage
privacy-concerned people from responding.
In this paper, as an alternative to direct surveys, we propose
online surveys with indirect reporting, where the questions a partic-
ipant answers are not about herself, but about her contacts. This
technique is known in the literature as the network scale-up method
[1, 2], and has been successfully used for public health. This ap-
proach has at least two major advantages with respect to direct
surveys. First, the survey can be designed so that no personal in-
formation is collected from the participant (i.e., it is completely
anonymous). Second, indirect reporting has a multiplicative effect,
since it reduces the number of responses required to achieve a spe-
cific population coverage. The loss in accuracy, due to respondents
not always having exact information about the health status of
others, may be compensated by the significant increase in coverage
(i.e., on average each respondent informs about the likely status of
around 100 other people, and this number is rather stable across
countries).
We have designed and deployed a system that implements the
network scale-up method via online anonymous surveys with in-
direct reporting, as part of the CoronaSurveys project [15]. This
system has surveys in multiple languages and allows reporting data
on the incidence of COVID-19 in all countries. The project team has
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promoted the survey via online social networks and personal con-
tacts. The system has been collecting data for more than 2 months
now, and has collected more than 13, 000 responses, reporting cases
in 70 countries. All the collected data is available to be openly used1.
In parallel with the data collection, the CoronaSurveys project has
been developing statistical techniques to estimate the incidence of
COVID-19 in different countries and geographical areas.
In the rest of this paper, we present the different elements of
the CoronaSurvey project, and compare our resulting estimates
with those obtained via other indirect methods and a wide sys-
tematic serology study conducted in Spain [6]. Our estimates are
surprisingly close to the values obtained in the serological study2.
From this, we conclude that anonymous open indirect surveys, in
combination with our proposed statistical techniques, provide a
cheap and flexible option for monitoring epidemics, especially in
countries with limited infrastructure.
2 ESTIMATES VIA ANONYMOUS SURVEYS
WITH INDIRECT REPORTING
This section describes the two main components of the Corona-
Survey project: collection of survey responses and estimation of
COVID-19 incidence from the collected responses.
2.1 Data Collection: The Survey
Our proposed surveys are carefully designed to avoid querying par-
ticipants about their own health status3, identity, or any personal
data. In order to provide data for estimating incidence, participants
answer three questions. First, they select a geographical area, which
can be a whole country or a region within a country. (The partici-
pant does not need to be a resident of that area.) Then, they answer
two simple questions about that area:
• How many people do you know in this geographical area?
(Please, consider only people whose current health status
you likely know.)
• As far as you know, how many of the above have had symp-
toms compatible with COVID-19 (or were diagnosed with
the disease)?
We aim at increasing participation by not asking for any personal
information (protecting the participant’s privacy), and by having
just two questions4. However, the lack of detailed information about
the participants makes the estimation process more challenging. In
particular, we do not control the spread of the survey and do not
have means to ensure that there is an adequate coverage, in terms
of regions, age groups and other demographic factors.
The main novelty of our proposed survey is that a participant
does not report on her own health status but on those of others. This
typically leads each participant to report on the health status of a
1https://github.com/GCGImdea/coronasurveys/tree/master/data
2Taking into account the sensitivity of the tests used in the serology study and that
there are roughly 34% asymptomatic cases.
3While in general reporting on one’s own health status without any identifying
information would not have privacy implications, it could increase the risk for de-
anonimization attacks if the raw data is publicly shared, or the survey system is
compromised.
4In the new version of the survey we have additional questions to estimate other
aspects of the epidemic, but the total number of questions we include remains very
small (10 or less), compared with most surveys (e.g., [5] has more than 30 questions).
large sample (around one hundred on average), which significantly
increases our coverage of the population. We believe that this is the
reason why, somewhat surprisingly, even with the limitations in
the available data and few responses, we can still obtain estimates
that are less than 4% away from the real value (see Section 3.3). We
believe that indirect reporting compensates significantly the biases
in the set of participants. Obvious advantages of this approach are
that it is very simple to deploy and can give very timely results.
We started the project by running discrete surveys in Spain and
evolved the system so that now it collects data continuously. The
survey was initially done via Twitter, but was quickly moved to
Google Forms. For privacy reasons, in May 2020 it has been moved
to a dedicated server running the web-based Limesurvey system.
We have been running the survey (starting with a simpler version)
in some countries for more than 3 months (since March 13). The
survey is now available in 57 languages. Participants can report
at the regional level in 149 countries and at the country level in
all countries of the world. We have already collected more than
15, 000 responses for almost 90 countries. This participation has
been obtained by advertising and promoting the survey in online
social networks, and via personal contacts. No incentive (economic
or otherwise) has been used to promote participation. In some
countries (e.g., Spain, Portugal, Ukraine, Brazil) the project received
media attention, which led to bursts in participation at specific
times. These burst do not seem to influence the results.
2.2 Computing Incidence Estimates
Country-wide and regional estimates. We use responses to our
survey to estimate the incidence of COVID-19 in different countries.
Respondents can report on the number of people they know for a
specific region or for the whole country. Currently, when the data
availability allows it, estimates for a given country are computed
based only on the regional responses, because we observed that
country-wide responses tend to introduce a geographical bias.
For instance, our initial estimates for Spain were ignoring re-
gional information, and considering all responses as referring to the
whole country. However, we observed that most of our responses
were actually from the region of Madrid (very likely because the
Spanish team members are based in Madrid), which is the most
affected region in Spain, and thus tended to report high incidence
ratios. This was in line with the prevalence in Madrid, but not
necessarily a good reflection of country-wide conditions. We then
computed new estimates by taking regional information into ac-
count and confirmed that we were initially over estimating the
number of cases in Spain.
We also decided to use only the responses that specify a region
as it is reasonable to assume that country-wide responses will share
a similar bias (coming from the most affected region)5. Note that
while we observed this bias in one specific dataset (Spain), similar
problems could arise in other countries. COVID-19 outbreaks have
been fairly localized in most countries, with different prevalence
observed at the region or state level. Thus, answers that provide
information within a region tend to lead to more reliable estimates
5This probably also results from the fact that we spread our survey through social
connections starting from our researchers based in Madrid.
CoronaSurveys: Using Surveys with Indirect Reporting to Estimate the Incidence and Evolution of Epidemics KDD WHM, August 24, 2020, San Diego, California USA
in general. We therefore plan to remove the country-wide option
in future survey updates.
COVID-19 incidence estimation – Region based approach. Assume
the country of interest is divided into 𝑘 regions. In each region 𝑖 ,
we get 𝑛𝑖 responses, where each response 𝑗 contains:
• a reach variable, 𝑟 𝑗𝑖 , which is the network size of participant
𝑗 (i.e., the number of people whose health she knows; answer
to the first survey question) and
• a count variable, 𝑐 𝑗𝑖 , which is the number of people (out
of the 𝑟 𝑗𝑖 reached) that are known to the respondent to be
showing symptoms compatible with COVID-19 (answer to
the second survey question),
for 𝑗 ∈ {1, . . . , 𝑛𝑖 }. Then, we obtain an estimate of the ratio of
people infected with symptoms in region 𝑖 , 𝑝𝑖 , using [1]
𝑝𝑖 =
∑𝑛𝑖
𝑗=1 𝑐
𝑗
𝑖∑𝑛𝑖
𝑗=1 𝑟
𝑗
𝑖
.
From the ratios 𝑝𝑖 of the different regions, we compute an es-
timate of the proportion of those infected with symptoms in the
country, 𝑝 , using a weighted sum of these ratios as follows.
𝑝 =
𝑘∑
𝑖=1
𝜔𝑖𝑝𝑖 ,
where 𝜔𝑖 is a proportional weight defined as
𝜔𝑖 =
𝑁𝑖
𝑁
,
where 𝑁𝑖 and 𝑁 are the populations of region 𝑖 and the whole
country, respectively. To build a confidence interval for 𝑝 , we need
to estimate its variance𝑉 (𝑝). To do so, we consider each region as a
stratum in a post-stratified random-sampling setting, and estimate
the variance of proportions for post-stratified sampling [8] as
𝑉 (𝑝) = 1 − 𝑓
𝑛
𝑘∑
𝑖=1
𝜔𝑖𝑆
2
𝑖 +
1 − 𝑓
𝑛2
𝑘∑
𝑖=1
(1 − 𝜔𝑖 )𝑆2𝑖 ,
where 𝑛 =
∑𝑘
𝑖 𝑛𝑖 and 𝑓 = 𝑛/𝑁 . The value 𝑆2𝑖 for each region can be
estimated using
𝑆2𝑖 =
𝑛𝑖∑
𝑗=1
(𝑝𝑖 𝑗 − 𝑝𝑖 )2
𝑛𝑖 − 1 ,
where 𝑝𝑖 𝑗 =
𝑐 𝑗𝑖
𝑟 𝑗𝑖
. We can then construct a confidence interval for 𝑝
as
𝑝 ± 1.96
√
𝑉 (𝑝).
Before generating an estimate for a given country at a given date,
we first clean the survey responses by identifying and removing
outliers. We declare a response to be an outlier if 𝑟 𝑗𝑖 , the number
of persons that the participant claims to know, is unusually large
(specifically, we remove entries where 𝑟 𝑗𝑖 is beyond 1.5 times the
interquartile range above the upper quartile). We also consider to
be outliers responses leading to a large ratio 𝑝𝑖 𝑗 of symptomatic
people reported (specifically, we remove entries in which the ratio
𝑐
𝑗
𝑖 /𝑟 𝑗𝑖 is above 0.3). We remove responses with large ratios because
we aim at surveying the general population, and not individuals
(such as doctors or nurses) who may be in contact with a large
number of symptomatic cases.
After outlier removal, for any given day we aggregate data from
that day and from previous days until we have at least 𝐴min re-
sponses. For the experiments we report here we set 𝐴min = 300, as
we observed empirically that this provides enough data to make our
estimate reliable. Since we usually do not get 𝐴min responses on a
given day for most countries, using data from previous days also
provides a rolling estimate, which has an implicit smoothing effect
on the estimate. From these responses, we exclude country-wide
responses (as discussed earlier) and then compute the value of 𝑝𝑖
for each region 𝑖 represented in the responses. Then, the estimate
of the proportion of people infected with symptoms in the country,
𝑝 , for the day is computed as shown above.
The described procedure produces reasonable estimates and
works well as long as we have a sufficiently large number of re-
sponses (per day). Hence, we have only applied this procedure
to generate estimates from data gathered in Spain, Portugal, and
Ukraine, countries from which we got the highest number of re-
sponses.
COVID-19 incidence estimation – Country based approach. For
countries where the number of survey responses is smaller (after
removing outliers), we have used a simpler estimation procedure.
Denote 𝑛𝑑 the number of responses collected on day 𝑑 for the given
country (counting both regional and country-wide responses after
removing outliers). If 𝑛𝑑 ≥ 𝑎min, we estimate the incidence of
COVID-19 in the country of interest using
𝑝𝑑 =
∑𝑛𝑑
𝑙=1 𝑐𝑙∑𝑛𝑑
𝑙=1 𝑟𝑙
,
where 𝑟𝑙 is the number of people a participant 𝑙 declares to know
in the first question of the survey, and 𝑐𝑙 is the number of people
(out of 𝑟𝑙 ) showing symptoms compatible with COVID-19, for 𝑙 ∈
{1, . . . , 𝑛𝑑 }. On the other hand, if 𝑛𝑑 < 𝑎min, we do not compute an
estimate for day 𝑑 . We instead aggregate the responses for day 𝑑 to
the responses for the subsequent days 𝑑 + 1, 𝑑 + 2, . . . until we have
a day 𝑑 ′ = 𝑑 +𝑚 such that 𝑛𝑚 = 𝑛𝑑 + 𝑛𝑑+1 + . . . + 𝑛𝑑+𝑚 ≥ 𝑎min
responses. In the experiments reported here we empirically chose
𝑎min = 30. We then compute the estimate 𝑝𝑑′ for day 𝑑 ′ as6
𝑝𝑑′ =
∑𝑛𝑚
𝑙=1 𝑐𝑙∑𝑛𝑚
𝑙=1 𝑟𝑙
.
The estimates 𝑝𝑑 and 𝑝𝑑′ are simple proportions and we con-
struct a 95% confidence interval for 𝑝 ∈ {𝑝𝑑 , 𝑝𝑑𝑚 } using confidence
intervals for binomial proportions as follows
𝑝 ± 1.96
√
𝑝 (1 − 𝑝)
𝑟
,
where 𝑟 =
∑
𝑙 𝑟𝑙 . A major limitation of this method is that we do not
obtain estimates for every day. However, we are constantly refining
these techniques, and trying new ways to obtain better estimates.
6We expect that better results may be achievable if 𝐴min and 𝑎min are selected as a
function of country population. We plan to investigate this in future work.
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3 VALIDATION
In the previous sections we introduced our strategy for indirect
reporting of the number of cases. Given the nature of an open and
anonymous survey, where data quality is much harder to enforce,
we soon identified the need for an independent estimator to which
we could compare the survey results. In most countries we had
access to time series with the number of official, RT-PCR confirmed,
cases and COVID-19 mortality data. Together these series allow
the derivation of a naive case fatality ratio (CFR).
Up to early May 2020 our running option for an independent
estimator was to use the CFR to estimate the current number of
cases in each country, as detailed in the next section. On May 13,
2020, a large-scale serology studywas reported for Spain [6] and this
provided a more precise and direct data collection for calibration.
3.1 Inferring Cases from Reported Mortality
In an ongoing epidemic, the current CFR should be calculated
by taking into account the number of deaths (𝑑) over the num-
ber of current cases with known outcomes (𝑐), since very recent
cases can still evolve as fatalities or recover [13]. This correc-
tion yields a corrected CFR (cCFR), more accurate than the naive
CFR that is often reported. To perform the correction we follow
the same methodology that is described in [16] as well as their
code in https://github.com/thimotei/CFR_calculation. We keep the
same estimates for the delay from case confirmation to death,
i.e., a Lognormal distribution with a mean delay of 13 days and
a standard deviation of 12.7 days. (Our code is available under
https://github.com/GCGImdea/coronasurveys.)
Under the assumption that the disease has similar mortality rates
for similar populations, it is possible to use stable cCFR estimates
to obtain a baseline, cCFR𝑏 , for COVID-19 and check how each
country’s current cCFR compares to that baseline, and hence infer
the proportion of cases that are being detected. In [16] the authors
keep a frequently updated estimate of the level of under-reporting
for several countries. As an example if cCFR𝑏 = 1% and a country
exhibits a cCFR = 2%, they infer that only 50% of the cases are being
detected. For our purposes, if we multiply the reported number of
cases by cCFRcCFR𝑏 , we obtain an estimate for the likely true number of
cases in that given country. In the example above we would have
multiplied the reported number of cases by cCFRcCFR𝑏 = 2.
The next step is to select a reference baseline. In [17] the authors
report, from a large sample of cases in China, a baseline cCFR𝑏 of
1.38% (𝑑𝑏 = 1, 023; and 𝑐𝑏 = 74, 130), and we have chosen to use
this baseline in our estimators. Still, given that several countries
(North Korea, New Zealand, and others) have stabilized the growth
of COVID-19 cases, it is possible to use the data in those countries
to also define a baseline. Following the Ln-Method in [9], we also
construct a confidence interval for the ratio cCFRcCFR𝑏 , at any given date.
We model the number of deaths 𝑑 using a binomial distribution
with parameters cCFR and 𝑐 (analogously, we refer to 𝑑𝑏 , cCFR𝑏 ,
and 𝑐𝑏 for our fixed baseline). Then, it can be shown that ln
(
𝑑/𝑐
𝑑𝑏/𝑐𝑏
)
is approximately normally distributed with mean ln
(
cCFR
cCFR𝑏
)
and
estimated variance ?ˆ?2 = 1/𝑑−1/𝑐+1/𝑑𝑏 −1/𝑐𝑏 . Finally, a 95% CI for
our ratio is given by (𝑟 · exp(−1.96 · ?ˆ?), 𝑟 · exp(1.96 · ?ˆ?)), where 𝑟
is the observed value of 𝑑/𝑐𝑑𝑏/𝑐𝑏 .
We observe that one limitation of resorting to reported mortality
data is that some countries might not properly report or classify
it as COVID-19 mortality. However, in countries with adequate
reporting, it is a useful source of calibration and independent esti-
mation.
3.2 Serology Study in Spain
On May 13, 2020 the Spanish Government published a first report
from a large-scale serology study that looked for COVID-19 anti-
bodies in the population [6]. Samples were collected from April 27
to May 11, and results made available from a group of 60, 897 par-
ticipants in the study, selected according to demographic criteria,
to obtain a representative sample of the population. Although both
IgM and IgG antibodies were measured, the report focuses on the
prevalence of SARS-Cov2 IgG antibodies. The overall prevalence
was reported as 5.0% (95% CI: 4.7%-5.4%), and regional variations
ranged from 1.1% in Ceuta to 11.3% in the Comunidad de Madrid.
The IgG test was found to have a sensitivity of 79% and specificity
of 100%. Given that, we can correct for false negatives and estimate
an overall infection rate of 6.33% (=0.05/0.79), with approximate 95%
CI: 5.95%-6.84%. Assuming an average time span of two weeks since
infection to the development of detectable levels of IgG [11], and
with a population in Spain of 46, 934, 628 persons, this leads to an
estimate of approximately 2, 970, 546 (95% CI: 2,792,313-3,208,190)
cumulative cases around the weeks from April 13 to 27 (in the
middle of this period, on April 20, the number of RT-PCR confirmed
cases was 200, 210, almost 15 times lower). Using the cumulative
mortality on May 11 (roughly two weeks after the likely infection
dates) of 26, 744, this leads to an estimated infection mortality rate
(IFR) of 0.9% (95% CI: 0.83%-0.96%)7. In Brasil, another large-scale
serology survey (with 25,025 participants) [7] recently provided an
estimated IFR of 1%, a value that is in line with our estimate for
Spain.
The Spanish study includes data on the proportions of IgG posi-
tives that had one or more symptoms, or were completely asymp-
tomatic. The proportion of IgG positives with some kind of symp-
toms (i.e., at least one symptom) was reported to be 66.27%. Fixing
this percentage, and assuming that most of the (officially reported)
RT-PCR confirmed cases were symptomatic, one can estimate about
1, 968, 550 persons with symptoms, and a CFR of around 1.36% (ac-
tually, very close to the value calculated for Wuhan at 1.38% [17]).
3.3 Comparing Estimates
Adopting as ground truth the serology-derived value of 6.33% cu-
mulative infections in the period from April 13 to 27 (which lead
to 79% IgG positives two weeks later, i.e. 5%), we compare this
ground-truth to our estimates in the same period. Since our esti-
mates, cCFR-based and survey-based, target symptomatic cases,
we need to scale them to total infections by dividing the estimates
by 0.66 (the ratio of symptomatic over total infections as reported
in the study [6]). We also show, for comparison, the number of
reported RT-PCR confirmed cases.
7The data of confirmed cases and mortality was extracted from [4] on the date of the
submission (May 20, 2020).
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Figure 1: Case estimates with 95% confidence bands for
Spain, April 13 to 27, 2020.
Figure 2: Relative accuracy vs. local coverage: For each re-
gion, we plot the relative error in our estimates as compared
to serology data, shown as a function of the relative reach
within the region. Higher reach (better coverage within a re-
gion) tends to lead to lower error.
As we can see in Figure 1 the official RT-PCR data is about an
order of magnitude less than the likely true rate of infected people
that is inferred from IgG prevalence, 6.33%. Figure 1 also shows that
both the cCFR-based estimate and the estimate derived from the
open survey closely track the IgG-prevalence value. Furthermore,
the confidence bands intersect throughout the period, with a clear
difference in amplitude due to the sample sizes. The average of the
cCFR estimates in the 15-day period was 6.56%, while that of the
survey-based estimates was 6.2%. This places them, respectively,
only 0.24% and 0.13% apart from the IgG reference value (average
relative difference of 3.72% and 2.05%, respectively). These results
show that open surveys can bring relevant data on the size of a
pandemic, which can be be useful when more reliable metrics are
not yet available or better estimates cannot be implemented in some
regions.
For further evaluation of our method we compare our estimates
to the serology data for each region in Spain as shown in Figure 2.
We plot the relative error in our estimate for a region as a function
of the relative coverage of our surveys for that region (reach divided
by population). Although we can see some variability, we note that
the trend is towards lower relative error as the reach increases.
4 EXPERIENCE USING OPEN SURVEYS IN
LMI COUNTRIES
We have obtained estimates for a number of countries. In particular,
we have received enough responses to estimate symptomatic cases
in 3 LMICs, namely Brazil, Ecuador, and Ukraine (see Tables 1 and
2).
In Brazil we have recent estimates for May 17, when the official
number of cumulative confirmed cases was 233, 142, and the official
number of cumulative fatalities was 15, 633. For that same date,
the estimate based on the cCFR is 2, 139, 681 (CI 95%: 2, 135, 408 -
2, 143, 963), 1.01% of the population, and the estimate based on 41
survey responses is 2, 120, 134 (CI 95%: 1, 195, 676 - 3, 044, 593), 1% of
the population. Not surprisingly, the estimated number of cases is
one order of magnitude larger than the number of confirmed cases.
However, it is remarkable how close the cCFR and survey-based
estimates are to each other, differing in less than 20, 000 cases (0.01%
of the population).
In Ecuador we also observe that the number of estimated cases
is at least one order of magnitude larger than the official number
of confirmed cases. However, we observe that the estimates from
cCFR and from the surveys are also very different. For instance,
we have estimates dated April 15, when the official number of
confirmed cases was 7, 603 and the official number of fatalities
was 355. Our case estimate for that date from the cCFR is 53, 435
(CI 53, 069 - 53, 804), 0.31% of the population, and the one from 30
survey responses is 274, 668 (CI 190, 236 - 359, 100), 1.61% of the
population. We observe a significant difference between the two
estimates, the one from the surveys being 5 times larger than the
cCFR-based one. This difference does not seem to be the result
of geographical bias, since few survey responses came from the
provinces with the largest number of cases (e.g., Guayas).
We observed a similar behavior in Ukraine where, again, the
estimates are at least one order of magnitude larger than the num-
ber of confirmed cases, and the number of estimated cases from
the surveys is one order of magnitude larger than the estimates
from cCFR. For instance, the latest direct estimate from (30) survey
responses was done on April 26, and has a value of 246, 646 (CI
107, 482 - 385, 811), 0.56% of the population, while the cCFR esti-
mate is 32, 078 (CI 31, 734 - 32, 426), 0.07% of the population. The
confirmed numbers of cases and fatalities on that date were 8, 617
and 209, respectively. This result is not due to a geographical bias,
since the region-based estimate for that same day from 300 survey
responses is 159, 529 (CI 62, 361 - 256, 696), 0.35% of the popula-
tion, which is lower, but still five times higher than the cCFR-based
estimate.
The results in Ecuador and Ukraine are puzzling, and we are
not able to explain them yet. Our current hypothesis is that these
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Country Date Cases Fatalities cCFR (CI 95%) Resp. CoronaSurveys (CI 95%)
Brazil May 17 233, 142 15, 633 2, 139, 681 (2, 135, 408 - 2, 143, 963) 41 2, 120, 134 (1, 195, 676 - 3, 044, 593)
Ecuador April 15 7, 603 355 53, 435 (53, 069 - 53, 804) 30 274, 668 (190, 236 - 359, 100)
Ukraine April 26 8, 617 209 32, 078 (31, 734 - 32, 426) 30 246, 646 (107, 482 - 385, 811)
Table 1: Summary of estimates for Brazil, Ecuador and Ukraine. Cases and Fatalities correspond to the official data on that
day, while cCFR and CoronaSurveys are estimates.
Country Date Cases cCFR CoronaSurveys
% pop. % pop. (CI 95%) % pop. (CI 95%)
Brazil May 17 0.11% 1.01% (1.00 - 1.01) 1.00% (0.56 - 1.43)
Ecuador April 15 0.04% 0.31% (0.31 - 0.31) 1.61% (1.11 - 2.10)
Ukraine April 26 0.02% 0.07% (0.07 - 0.07) 0.56% (0.25 - 0.88)
Table 2: Summary of estimates for Brazil, Ecuador and
Ukraine in percentage of the country population.
countries use different criteria for reporting cases and fatalities than
the countries we use as reference. This may cause the cCFR-based
estimate to be unreliable. We have deployed additional questions
in the survey that we believe can be used to track the difference.
The good news is that this can be done with very little effort, and
we do not need a lot of responses to have enough information to
have solid conjectures.
5 DISCUSSION
By now it is clear that relying only on confirmed cases and fatalities
to measure the true size of a growing pandemic is not a good idea. It
is possible to use this data to derive estimates, like the one we obtain
here based on the cCFR, that are reasonably reliable in countries
with a good reporting system. This has been shown in the case of
Spain using the ground truth provided by a serological study. The
same study indicates that open anonymous surveys with indirect
reporting also provide estimates that are close to the real values. The
matching between cCFR-based and survey-based estimates has also
been observed in Brazil. However, we have found countries in which
there is no ground truth, and the cCFR-based and survey-based
estimates differ significantly. We are investigating this further by
adding new questions to the surveys in these countries, which will
provide additional information on the causes of these discrepancies.
We are aware that having open anonymous surveys prevents a
tight control of the population of participants. Hence, our responses
may be suffering from strong biases: for example, they may be close
geographically and socially to the team members, which are the
ones promoting the survey. We are also aware that the set of people
and cases participants report are possibly not disjoint. Interestingly,
until now the only bias that we have observed to be relevant is
the geographical bias. Initial studies done via simulation hint that
the intersection of contacts among participants does not seem to
have much influence on the estimates. However, more experiments
are required. In fact, new questions have been added to the survey
to evaluate the level of overlapping, and estimate the propagation
graph of participation.
However, we plan to explore ways to influence and select the
population of participants. One line to follow is the use of targeted
campaigns in social networks and web ads (using Facebook Ads or
Google Ads), in which we have control over who sees a given ad
promoting the survey. This will allow targeting participants from
certain geographical areas and certain demographic profiles. In fact,
we have started a exploratory campaign using Facebook Ads in
Brazil.
While we only present here techniques for obtaining estimates
on the number of people infected with COVID-19, we are designing
new surveys that will hopefully allow us to estimate other important
parameters of the pandemic, like the number of newly infected
cases, the reproduction number, or the forecast needs of health
equipment and infrastructures.
We believe that a survey system like the CoronaSurveys project is
especially suited for LMICs, since the cost of preparing and deploy-
ing a survey is extremely small, participants can use very simple
devices to fill the survey (since it is web based), and the number
of participants required to have information on the pandemic is
rather low. Having a uniform approach to obtain this information
in many countries also makes the process especially interesting,
since it avoids the current problems with different ways of counting
and measuring.
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